...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A).
【24h】

Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A).

机译:法莫替丁和西咪替丁之间通过人肾有机离子转运蛋白(SLC22A)的不同转运特性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Histamine H(2) receptor antagonist famotidine and cimetidine are commonly used for treatment of gastrointestinal ulcer diseases. Inasmuch as these drugs are mainly secreted by renal tubules, dosages have been adjusted according to renal function. Although many studies have been performed on the molecular mechanisms of renal handling of cimetidine, little is known about that of famotidine. In this study, to examine the recognition and transport of famotidine by human organic anion transporters (OATs; hOAT1, hOAT3) and human organic cation transporter (OCT; hOCT2), the uptake studies using Xenopus laevis oocytes were performed in comparison with cimetidine. The half-maximal inhibitory concentrations of famotidine for [(3)H]estrone sulfate transport by hOAT3 and [(14)C]tetraethylammonium transport by hOCT2 (300 渭M and 1.8 mM, respectively) were higher than those of cimetidine (53 and 67 渭M, respectively). While cimetidine inhibited p-[(14)C]aminohippurate transport by hOAT1 in a concentration dependent manner, famotidine did not affect it at 5 mM. In addition, hOAT3 mediated famotidine uptake, but hOAT1 and hOCT2 did not show famotidine transport. These results indicate that there are marked differences between famotidine and cimetidine in the recognition and transport by organic ion transporters and that hOAT3 contributes to the renal tubular secretion of famotidine. Present findings should be useful information to understand the renal handling of famotidine and cimetidine.
机译:组胺H(2)受体拮抗剂法莫替丁和西咪替丁通常用于治疗胃肠道溃疡疾病。由于这些药物主要由肾小管分泌,因此已根据肾功能调整剂量。尽管已经对西咪替丁的肾脏操作的分子机制进行了许多研究,但对法莫替丁的知之甚少。在这项研究中,为了检查法莫替丁被人有机阴离子转运蛋白(OATs; hOAT1,hOAT3)和人有机阳离子转运蛋白(OCT; hOCT2)的识别和转运,与西咪替丁比较,使用非洲爪蟾卵母细胞进行了摄取研究。法莫替丁对hOAT3转运[[3)H]雌酮硫酸盐和hOCT2对[[14] C]四乙铵转运的半数最大抑制浓度(分别为300μM和1.8 mM)高于西咪替丁(53和51分别为67μM)。尽管西咪替丁以浓度依赖性方式抑制hOAT1对p-[(14)C]氨基马尿酸盐的转运,但法莫替丁在5 mM时不影响其转运。此外,hOAT3介导法莫替丁摄取,但hOAT1和hOCT2没有显示法莫替丁转运。这些结果表明法莫替丁和西咪替丁之间在有机离子转运蛋白的识别和转运方面存在显着差异,并且hOAT3有助于法莫替丁的肾小管分泌。目前的发现应该是了解肾脏对法莫替丁和西咪替丁的处理的有用信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号